SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging following a preliminary business update that highlighted a massive jump in gross margins to 15-17% and record-breaking new orders exceeding $60 billion. The community is actively debating the potential for a major short squeeze and questioning the sustainability of these margins, while bulls are focused on the stock's significant undervaluation relative to its surging demand and backlog.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is experiencing heightened volatility as the community debates whether recent price action represents a classic liquidity trap or an accumulation phase for its AI-centric infrastructure. Investors are closely monitoring its technical performance against broader altcoin market trends, with sentiment divided between short-term bearishness and long-term conviction in its utility narrative.

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgo Bioworks is experiencing heightened investor scrutiny and volatility as the company pivots toward autonomous labs and AI-driven biological research, with community members fiercely debating whether this shift represents a genuine path to scalability or a continuation of historical execution struggles. While some investors are accumulating shares based on potential long-term infrastructure value and government-backed biosecurity contracts, others remain deeply skeptical due to persistent cash burn, declining revenue, and the risk of further share dilution.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is currently trending as investors weigh semiconductor sector volatility and broader market rotation against geopolitical uncertainties in the Middle East, while community discussions remain focused on navigating short-term price swings through leveraged ETF trading and analyzing AI-driven capex trends.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF is trending as investors grapple with massive volatility driven by extreme leverage in the semiconductor sector and concerns over potential labor strikes at major chip producers. Community discussion is heavily focused on the concentration of the index in memory-chip giants like Samsung and SK Hynix, as traders debate whether this represents a structural AI-driven growth cycle or a highly susceptible bubble.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is trending as investors aggressively hedge against the Nasdaq amidst persistent geopolitical tensions in the Middle East and growing skepticism regarding the AI-driven rally. Community members remain deeply divided, with many traders scalping the inverse ETF for short-term gains while others warn of the structural decay inherent in leveraged products during volatile market conditions.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is facing volatility despite reporting its strongest quarter in history, with community discussion centered on whether the post-earnings dip represents a prime accumulation opportunity or a signal of deeper credit risk. While some investors are highlighting the company's hyper-growth and successful expansion into new markets, others remain concerned about rising delinquency provisions and the company's decision to aggressively scale its unsecured lending portfolio.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery shareholders are preparing to vote on a 110 billion dollar merger with Paramount Skydance, an event that has triggered intense industry debate over media consolidation, executive compensation, and the potential impact on content creation. Community discussions are highly polarized, balancing optimism regarding the 31 dollar per share cash payout against significant concerns about antitrust risks, the massive debt burden of the combined entity, and the future of creative independence.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is facing intense scrutiny as investors weigh solid business growth and increasing institutional accumulation against concerns regarding share dilution and historical post-earnings volatility. While some community members remain bullish on the long-term fintech ecosystem, sentiment is heavily divided as participants brace for potential price swings surrounding upcoming quarterly results.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet (GOOG) is trending as investors focus on its upcoming earnings release, specifically watching for guidance on AI infrastructure capital expenditures and its integration of artificial intelligence models. Market sentiment remains split, with community discussions highlighting debates over whether the company's aggressive spending is a necessary driver of future AI dominance or a potential pressure point on margins.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?

bioAffinity's CyPath Lung sales momentum is gaining traction, but wider losses, funding needs and regulatory risks keep pressure on the stock.

bioAffinity Technologies Quarterly CyPath Lung Sales Double to New Record as Commercial Momentum Continues

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced continued acceleration in commercial sales for CyPath Lung, its noninvasive lung...

bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer diagnostics and targeted therapeutics, will present preclinical findings for a novel therapeutic approach that uses small interfering RNAs (siRNAs) that kill squamous and basal skin cancer...

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering PR Newswire JERSEY CITY, N.J., June 18, 2026 JERSEY CITY,N.J., June 18, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a...

bioAffinity Technologies Announces Closing of $3.2 Million Offering

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced the closing of its previously announced public offering of securities as described...

WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering

WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering PR Newswire JERSEY CITY, N.J., June 17, 2026 JERSEY CITY, N.J., June 17, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a...

bioAffinity Technologies Announces Pricing of $3.2 Million Offering

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced that it has priced a Public Offering of securities as described below for aggregate...

bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing cancer diagnostics including CyPath Lung, the Companys commercially available test for early-stage lung cancer, announced a webinar on July 21, 2026, featuring clinical experts discussing emerging approaches to...

Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced the Society for Advanced Bronchoscopy (SAB) will host a webinar on CyPath Lungs expanding role in pulmonary, oncology and surgical...

bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath Lung Technology

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer diagnostics including CyPath Lung, the Companys commercially available test for early-stage lung cancer, today announced it has received notification of allowance from the Mexican Institute of...

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

BioAffinity Technologies Inc

BIAF Stock Gains As CyPath Sales Surge 146% In Q1

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

BIAFBioAffinity Technologies Inc

Fundamentals

Latest BIAF News